Biblio
General condition and comorbidity of long-term survivors of adult acute lymphoblastic leukemia. Haematologica. 2023.
Inotuzumab Ozogamicin as Induction Therapy for Patients Older Than 55 Years With Philadelphia Chromosome-Negative B-Precursor ALL. J Clin Oncol. 2023:JCO2300546.
Insights into IGH clonal evolution in BCP-ALL: frequency, mechanisms, associations, and diagnostic implications. Front Immunol. 2023;14:1125017.
Treatment of adult ALL patients with third-generation CD19-directed CAR T cells: results of a pivotal trial. J Hematol Oncol. 2023;16(1):79.
[Osteonecrosis-severe side effect of treatment for acute lymphoblastic leukemia]. Orthopadie (Heidelb). 2022.
. .
MRD in adult Ph/BCR-ABL-negative ALL: how best to eradicate?. Hematology Am Soc Hematol Educ Program. 2021;2021(1):718-725.
. .
Blinatumomab for Acute Lymphoblastic Leukemia Relapse After Allogeneic Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2019.
Outcomes of allogeneic stem cell transplantation after inotuzumab ozogamicin treatment for relapsed or refractory acute lymphoblastic leukemia. Biol Blood Marrow Transplant. 2019.